RachelERauMD

PubMed

• 1 citations
  SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731.
  Caitlin W Elgarten, John A Kairalla, Joel C Thompson, Tamara P Miller, Cindy Wang, Susan Conway, Mignon L Loh, Elizabeth A Raetz, Sumit Gupta, Rachel E Rau, Anne Angio...> ;Ejhaem. 2023 Aug 1
• 9 citations
  SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia.
  Courtney Chambers, Katerina Cermakova, Yuen San Chan, Kristen Kurtz, Katharina Wohlan, Andrew Henry Lewis, Christiana Wang, Anh Pham, Milan Dejmek, Michal Sala, Mario ...> ;Cancer Research. 2023 Apr 4
• SOHO State of the Art Updates and Next Questions | Optimal Timing of Blinatumomab for the Treatment of B-Acute Lymphoblastic Leukemia.
  Ashley Pinchinat, Sumit Gupta, Stacy L Cooper, Rachel E Rau> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Mar 1
• 1 citations
  Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia.
  Lik Wee Lee, Meenakshi Devidas, Yunfeng Dai, Karen R Rabin, Sumit Gupta, Mignon L Loh, Ilan R Kirsch, Brent Wood, Rachel E Rau, Fries, C.> ;Haematologica. 2023 Mar 1
• 9 citations
  Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study.
  Luke Maese, Mignon L Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey A Silverman, Lewis B Silverman, Elizabeth A Ra...> ;Blood. 2023 Feb 16
• 2 citations
  Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's On...
  Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, Zhiguo Chen, Susan Conway, Meenakshi Devidas, Sumit Gupta, John A Kairalla, Jennifer L McNeer, Maureen M O'Brien,...> ;Pediatric Blood & Cancer. 2022 Nov 1
• 5 citations
  Constitutive loss of DNMT3A causes morbid obesity through misregulation of adipogenesis.
  Ayala Tovy, Jaime M Reyes, Linda Zhang, Yung-Hsin Huang, Carina Rosas, Alexes C Daquinag, Anna Guzman, Raghav Ramabadran, Chun-Wei Chen, Tianpeng Gu, Sinjini Gupta, La...> ;Elife. 2022 May 30
• 15 citations
  Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
  Luke Maese, Rachel E Rau> ;Frontiers in Pediatrics. 2022 Jan 1
• 3 citations
  Murine Models of Acute Myeloid Leukemia.
  Kristen J Kurtz, Shannon E Conneely, Madeleine O'Keefe, Katharina Wohlan, Rachel E Rau> ;Frontiers in Oncology. 2022 Jan 1
• 5 citations
  Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities.
  Jason H. Rogers, Rohit Gupta, Jaime M. Reyes, Michael C. Gundry, Geraldo Medrano, Anna Guzman, Rogelio Aguilar, Shannon E Conneely, Tidie Song, Cade Johnson, Sean Barn...> ;Blood Advances. 2021 Oct 12
• 6 citations
  Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia.
  Shannon E Conneely, Casey L. McAtee, Rohit Gupta, Joseph Lubega, Michael E. Scheurer, Rachel E. Rau> ;Blood Advances. 2021 Oct 7
• 13 citations
  Can recombinant technology address asparaginase Erwinia chrysanthemi shortages
  Luke Maese, Carmelo Rizzari, Russell Coleman, Austin Power, Inge M. van der Sluis, Rachel E. Rau> ;Pediatric Blood & Cancer. 2021 Jun 8
• 11 citations
  Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
  Ayala Tovy, Carina Rosas, Amos Gaikwad, Geraldo Medrano, Linda Zhang, Jaime M. Reyes, Yung-Hsin Huang, Tastuhiko Arakawa, Kristen Kurtz, Shannon E Conneely, Anna Guzma...> ;Haematologica. 2021 Jun 3
• 8 citations
  Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
  Rachel E. Rau, Yunfeng Dai, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler-McKay, Anne L. Angiolillo, Reuven J. Schore, Michael J. Burke, Wanda L. Salzer, Nyla...> ;Pediatric Blood & Cancer. 2021 Feb 9
• 2 citations
  An Mb1-Cre-driven oncogenic Kras mutation results in a mouse model of T-acute lymphoblastic leukemia/lymphoma with short latency and high penetrance.
  Jacob J. Junco, Taylor Chen, Raushan Rashid, Maci Terrell, Vincent U. Gant, Matthew Miller, Rachel E. Rau, H. Daniel Lacorazza, Karen R. Rabin> ;Leukemia. 2021 Jun 1
• 2 citations
  How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.
  Sumit Gupta, Shannon L. Maude, Maureen M. O'Brien, Rachel E. Rau, Jennifer L. McNeer> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Sep 1
• 11 citations
  Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia
  Shannon E Conneely, Stacy Cooper, Rachel E. Rau> ;Frontiers in Oncology. 2020 Jul 16
• SIRPAssing other xenograft murine models
  Rachel E. Rau> ;Blood. 2020 May 7
• 18 citations
  Cutting to the Front of the Line: Immunotherapy for Childhood Acute Lymphoblastic Leukemia
  Jennifer L. McNeer, Rachel E. Rau, Sumit Gupta, Shannon L. Maude, Maureen M. O'Brien> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2020 Apr 21
• 38 citations
  Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children'...
  Eric S. Schafer, Rachel E. Rau, Stacey L. Berg, Xiaowei Liu, Charles G. Minard, Alexander J.R. Bishop, J. Carolina Romero, M. John Hicks, Marvin D. Nelson, Stephan D. ...> ;Pediatric Blood & Cancer. 2020 Feb 1
• 15 citations
  Experience with ponatinib in paediatric patients with leukaemia.
  Jenna Rossoff, Van Huynh, Rachel E. Rau, Margaret E. Macy, Maria Luisa Sulis, Kirk R. Schultz, Michael J. Burke, Uma H. Athale, Maureen M. O'Brien, John Gregory, Inge ...> ;British Journal of Haematology. 2020 Jan 24
• 24 citations
  The genomics of acute myeloid leukemia in children
  Shannon E Conneely, Rachel E. Rau> ;Cancer Metastasis Reviews. 2020 Mar 1
• 29 citations
  A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells
  Chun Shik Park, Andrew Lewis, Taylor J Chen, Cory Seth Bridges, Ye Shen, Koramit Suppipat, Monica Puppi, Julie A. Tomolonis, Paul Pang, Toni-Ann Mistretta, Leyuan Ma, ...> ;Blood. 2019 Nov 28
• 7 citations
  Incidence and predictors of treatment-related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia.
  Saman K. Hashmi, Shoba A. Navai, Tiffany M. Chambers, Michael E. Scheurer, M. John Hicks, Rachel E. Rau, Maria M. Gramatges> ;Pediatric Blood & Cancer. 2020 Feb 1
• 2 citations
  Ponatinib use in two pediatric patients with relapsed Ph + ALL with ABL1 kinase domain mutations.
  Stephanie E. Gruner, Hadi Sayeed, Lizmery Suarez-Ferguson, Cintia R. Perez, Rayne H. Rouce, Kevin E. Fisher, Rachel E. Rau> ;Pediatric Hematology and Oncology. 2019 Sep 11
• Join now to see all

Abstracts/Posters

• Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or...
  Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Novel Short Latency, High Penetrance Model of KRAS Mutation-Driven T-Cell Acute Lymphoblastic Leukemia
  Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Targeting Activated Signaling Pathways for the Treatment of IKZF1-Deleted B Lymphoblastic Leukemia
  Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018